The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Open accessAbstract
Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to receive toripalimab or placebo in combination with paclitaxel plus cisplatin (TP) every 3 weeks for up to 6 cycles, followed by toripalimab or placebo maintenance. At the prespecified final analysis of progression-free survival (PFS), a significant improvement in PFS is observed for the toripalimab arm over the placebo arm (hazard ratio [HR] = 0.58; 95% CI, 0.46-0.74; p < 0.0001). The prespecified interim analysis of overall survival (OS) also reveals a significant OS improvement for patients treated with toripalimab plus TP over placebo plus TP (HR = 0.58; 95% CI, 0.43-0.78; p = 0.0004). The incidences of grade ≥3 treatment-emergent adverse events are similar between the two arms. Toripalimab plus TP significantly improves PFS and OS in patients with treatment-naïve, advanced ESCC, with a manageable safety profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Cao, W., Chen, H.-D., Yu, Y.-W., Li, N., & Chen, W.-Q. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001474 · Cited by 2,865
Epidemiology of Esophageal Squamous Cell Carcinoma
Abnet, C. C., Arnold, M., & Wei, W.-Q. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.08.023 · Cited by 1,672
Sun, J.-M., Shen, L., Shah, M. A., Enzinger, P., Adenis, A., Doi, T., Kojima, T., Metges, J.-P., Li, Z., Kim, S.-B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01234-4 · Cited by 1,635
Self-citationRizvi, N. A., Mazières, J., Planchard, D., Stinchcombe, T. E., Dy, G. K., Antonia, S. J., Horn, L., Lena, H., Minenza, E., Mennecier, B., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70054-9 · Cited by 1,415
Kato, K., Cho, B. C., Takahashi, M., Okada, M., Lin, C.-Y., Chin, K., Kadowaki, S., Ahn, M.-J., Hamamoto, Y., Doki, Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30626-6 · Cited by 1,213
Kojima, T., Shah, M. A., Muro, K., Francois, E., Adenis, A., Hsu, C.-H., Doi, T., Moriwaki, T., Kim, S.-B., Lee, S.-H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01888 · Cited by 1,126
Self-citationAjani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0033 · Cited by 1,059
Qiu, H., Cao, S., & Xu, R. (2021) · Cancer Communications · doi:10.1002/cac2.12197 · Cited by 1,015
Self-citationLuo, H., Lu, J., Bai, Y., Mao, T., Wang, J., Fan, Q., Zhang, Y., Zhao, K., Chen, Z., Gao, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.12836 · Cited by 803
Self-citationWang, F., Wei, X. L., Wang, F. H., Xu, N., Shen, L., Dai, G. H., Yuan, X. L., Chen, Y., Yang, S. J., Shi, J. H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz197 · Cited by 455
Self-citationMai, H.-Q., Chen, Q.-Y., Chen, D., Hu, C., Yang, K., Wen, J., Li, J., Shi, Y.-R., Jin, F., Xu, R., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01444-0 · Cited by 396
Self-citationWang, F.-H., Wei, X.-L., Feng, J., Li, Q., Xu, N., Hu, X.-C., Liao, W., Jiang, Y., Lin, X.-Y., Zhang, Q.-Y., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02712 · Cited by 348
Self-citationConstantinidou, A., Alifieris, C., & Trafalis, D. T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.008 · Cited by 342
Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B. C., Nor, I. M., Ng, M., Chen, L. T., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy498 · Cited by 289
Self-citationTang, B., Chi, Z., Chen, Y., Liu, X., Wu, D., Chen, J., Song, X., Wang, W., Dong, L., Song, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3922 · Cited by 168
Self-citationLawson, N. L., Dix, C. I., Scorer, P., Stubbs, C. J., Wong, E., Hutchinson, L., McCall, E. J., Schimpl, M., DeVries, E., Walker, J., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0372-z · Cited by 89
Sheng, X., Chen, H., Hu, B., Yao, X., Liu, Z., Yao, X., Guo, H., Hu, Y., Ji, Z., Luo, H., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2210 · Cited by 82
Self-citationWei, X., Ren, C., Wang, F., Zhang, Y., Zhao, H., Zou, B., Wang, Z., Qiu, M., Zhang, D., Luo, H., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12068 · Cited by 57
Self-citationWang, Z., Ying, J., Xu, J., Yuan, P., Duan, J., Bai, H., Guo, C., Li, L., Yang, Z., Wan, R., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13770 · Cited by 49
Self-citationRen, C., Wei, X., Xu, N., Shen, L., Dai, G., Yuan, X., Chen, Y., Yang, S., Shi, J., Hu, X., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.e15083 · Cited by 8
Self-citation
Cited by
Lu, S., Zhang, W., Wu, L., Wang, W., Zhang, P., Neotorch Investigators, Fang, W., Xing, W., Chen, Q., Yang, L., et al. (2024) · JAMA · doi:10.1001/jama.2023.24735 · Cited by 383
Self-citationXu, J., Kato, K., Raymond, E., Hubner, R. A., Shu, Y., Pan, Y., Park, S. R., Ping, L., Jiang, Y., Zhang, J., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00108-0 · Cited by 338
Self-citationYang, H., Wang, F., Hallemeier, C. L., Lerut, T., & Fu, J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02226-8 · Cited by 299
Self-citationMai, H.-Q., Chen, Q.-Y., Chen, D., Hu, C., Yang, K., Wen, J., Li, J., Shi, Y., Jin, F., Xu, R., et al. (2023) · JAMA · doi:10.1001/jama.2023.20181 · Cited by 279
Self-citation
Metadata
- Authors
- Wang, Z.-X., Cui, C., Yao, J., Zhang, Y., Li, M., Feng, J., Yang, S., Fan, Y., Shi, J., Zhang, X., Shen, L., Shu, Y., Wang, C., Dai, T., Mao, T., Chen, L., Guo, Z., Liu, B., Pan, H., Cang, S., Jiang, Y., Wang, J., Ye, M., Chen, Z., Jiang, D., Lin, Q., Ren, W., Wang, J., Wu, L., Xu, Y., Miao, Z., Sun, M., Xie, C., Liu, Y., Wang, Q., Zhao, L., Li, Q., Huang, C., Jiang, K., Yang, K., Li, D., Liu, Y., Zhu, Z., Chen, R., Jia, L., Li, W., Liao, W., Liu, H.-X., Ma, D., Ma, J., Qin, Y., Shi, Z., Wei, Q., Xiao, K., Zhang, Y., Zhang, Y., Chen, X., Dai, G., He, J., Li, J., Li, G., Liu, Y., Liu, Z., Yuan, X., Zhang, J., Fu, Z., He, Y., Ju, F., Liu, Z., Tang, P., Wang, T., Wang, W., Zhang, J., Luo, X., Tang, X., May, R., Feng, H., Yao, S., Keegan, P., Xu, R.-H., & Wang, F.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 40
- Issue
- 3
- Pages
- 277-288.e3
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W4214915284
- Cited by
- 546
- References
- 23
- FWCI
- 97.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.